{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:02:58Z","timestamp":1788973378929,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["46218"],"award-info":[{"award-number":["46218"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jchromb.2025.124891","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:37:13Z","timestamp":1764981433000},"page":"124891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Simultaneous chromatographic quantification of upadacitinib, nilotinib, and tryptophan decoding myeloid leukemia and liver cancer integrated with ELISA and Flow cytometry"],"prefix":"10.1016","volume":"1270","author":[{"given":"Ahmed M.","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabeay Y.A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Abd-Rabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr M.","family":"Badawey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda M.","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124891_bb0005","doi-asserted-by":"crossref","unstructured":"-F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 68 (2018) 394\u2013424. doi: https:\/\/doi.org\/10.3322\/caac.21492.","DOI":"10.3322\/caac.21492"},{"key":"10.1016\/j.jchromb.2025.124891_bb0010","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.jchromb.2025.124891_bb0015","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jchromb.2025.124891_bb0020","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jchromb.2025.124891_bb0025","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","article-title":"Epidemiology of hematological malignancies","volume":"18","author":"Rodriguez-Abreu","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0030","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/jama.2025.0220","article-title":"Chronic myeloid leukemia: a review","volume":"333","author":"Jabbour","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jchromb.2025.124891_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6000\/1927-7229.2012.01.01.11","article-title":"Innovations in analytical oncology - status quo of mass spectrometry-based diagnostics for malignant tumor","volume":"1","author":"Takeda","year":"2012","journal-title":"J. Anal. Oncol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s43621-024-00575-x","article-title":"Computational intelligence techniques for achieving sustainable development goals in female cancer care","volume":"5","author":"Bukke","year":"2024","journal-title":"Discov. Sustain."},{"key":"10.1016\/j.jchromb.2025.124891_bb0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1309\/AJCPUN89CXERVOVH","article-title":"Chronic myelogenous leukemia, BCR-ABL1+","volume":"132","author":"Vardiman","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0050","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1182\/blood.V114.22.1126.1126","article-title":"International randomized study of interferon vs STI571 (IRIS) 7-year follow-up: sustained survival and low risk of progression in chronic myeloid leukemia patients on imatinib","volume":"114","author":"Deininger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jchromb.2025.124891_bb0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.critrevonc.2011.08.002","article-title":"Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions","volume":"82","author":"Valent","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0060","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.3390\/cancers14143300","article-title":"Mechanisms of resistance and implications for treatment strategies in chronic myeloid leukaemia","volume":"14","author":"Poudel","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jchromb.2025.124891_bb0065","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1182\/blood-2014-09-594432","article-title":"Vascular safety issues in CML patients treated with tyrosine kinase inhibitors: a review","volume":"126","author":"Valent","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jchromb.2025.124891_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40164-020-00185-z","article-title":"Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study","volume":"9","author":"Ning","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0075","author":"RINVOQ (upadacitinib)"},{"key":"10.1016\/j.jchromb.2025.124891_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.2015.233","article-title":"The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours","volume":"113","author":"Thomas","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jchromb.2025.124891_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3892\/ijo.2022.5340","article-title":"Combined inhibition of IL-6 and IL-8 pathways suppresses ovarian cancer cell viability and migration and tumor growth","volume":"60","author":"Zhang","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2013.01.037","article-title":"Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC\/MS\/MS","volume":"926","author":"Andriamanana","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124891_bb0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cca.2011.02.023","article-title":"Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC\/MS-MS","volume":"412","author":"Bouchet","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2025.124891_bb0100","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.leukres.2009.11.009","article-title":"Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography","volume":"34","author":"Davies","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jchromb.2025.124891_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123917","article-title":"Development and validation of a multiplex HPLC-MS\/MS assay for the monitoring of JAK inhibitors in patient plasma","volume":"1230","author":"Tachet","year":"2023","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124891_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123071","article-title":"Simultaneous measurement of upadacitinib and methotrexate by UPLC-MS\/MS and its pharmacokinetic application in rats","volume":"1188","author":"Li","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124891_bb0115","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/rheumatology\/kead448","article-title":"Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases","volume":"63","author":"Taylor","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.jchromb.2025.124891_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpba.2014.01.040","article-title":"Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC-MS\/MS: application to a pharmacokinetic study","volume":"94","author":"Veeraraghavan","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124891_bb0125","article-title":"Sustainable spectrophotometric determination of antihypertensive medicines reducing COVID-19 risk via paired wavelength data processing technique\u2014assessment of purity, greenness and whiteness","volume":"29","author":"El-Hanboushy","year":"2022","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2025.124891_bb0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1515\/CCLM.2010.105","article-title":"Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection","volume":"48","author":"Xiang","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2025.124891_bb0135","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/bmc.445","article-title":"Simultaneous determination of tryptophan and kynurenine in serum by HPLC with UV and fluorescence detection","volume":"18","author":"Vignau","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2025.124891_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122466","article-title":"Chromatographic bioanalytical assays for targeted covalent kinase inhibitors and their metabolites","volume":"1162","author":"Retmana","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124891_bb0145","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1038\/s41598-025-88488-1","article-title":"Anti-colorectal cancer activity of constructed oleogels based on encapsulated bioactive canola extract in lecithin for edible semisolid applications","volume":"15","author":"Akl","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2025.124891_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133942","article-title":"Synthesis of new imidazole\u2013triazole\u2013glycoside hybrids as anti-breast cancer candidates","volume":"1270","author":"El-Sofany","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jchromb.2025.124891_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136424","article-title":"Microwave-assisted synthesis of spirothiazolidine derivatives to induce cervical cancer cell death\u2013mediated apoptosis in vitro","volume":"1294","author":"El-Sofany","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jchromb.2025.124891_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141471","article-title":"Novel indoline analogues reverse resistant breast cancer via P-glycoprotein inhibition and apoptotic genes modulation","volume":"1331","author":"Mansour","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jchromb.2025.124891_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2023.103252","article-title":"Utilization of lactobacilli extracts as antibacterial agent and to induce colorectal cancer cells apoptosis: application in white soft cheese","volume":"56","author":"El-Ssayad","year":"2023","journal-title":"Food Biosci."},{"key":"10.1016\/j.jchromb.2025.124891_bb0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ecolind.2015.08.003","article-title":"Sustainable development goals: a need for relevant indicators","volume":"60","author":"H\u00e1k","year":"2016","journal-title":"Ecol. Indic."},{"key":"10.1016\/j.jchromb.2025.124891_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.trac.2014.07.009","article-title":"Multivariate experimental design in environmental analysis, TrAC","volume":"62","author":"Callao","year":"2014","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2025.124891_bb0180","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1039\/C6GC00611F","article-title":"Updating and further expanding GSK\u2019S solvent sustainability guide","volume":"18","author":"Alder","year":"2016","journal-title":"Green Chem."},{"key":"10.1016\/j.jchromb.2025.124891_bb0185","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1080\/10826070903249799","article-title":"Development and validation of stability-indicating high performance liquid chromatographic (HPLC) and DD1-spectrophotometric assays for etodolac in bulk form and in pharmaceutical dosage form","volume":"32","author":"Saleh","year":"2009","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0190","first-page":"141","article-title":"UV spectrophotometric method development and validation of vonoprazan fumarate in bulk and pharmaceutical dosage form; green profile evaluation via eco-scale and GAPI tools","volume":"66","author":"Saleh","year":"2023","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.jchromb.2025.124891_bb0195","first-page":"628","article-title":"Green synthesis of zinc oxide nanoparticles from Schefflera arboricola extract to enhance onion resistance to downy mildew, promote growth, and contribute to sustainability, Egypt","volume":"103","author":"El-Abeid","year":"2025","journal-title":"J. Agric. Res."},{"key":"10.1016\/j.jchromb.2025.124891_bb0200","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1080\/10408347.2023.2253321","article-title":"Drilling into \u201cquality by design\u201d approach for analytical methods","volume":"54","author":"Chiarentin","year":"2024","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jchromb.2025.124891_bb0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/chromsci\/bmy014","article-title":"A capillary zone electrophoresis method with multiresponse chemometric optimization for the simultaneous determination of zofenopril calcium and hydrochlorothiazide in presence of hydrochlorothiazide major impurities","volume":"56","author":"Fayed","year":"2018","journal-title":"J. Chromatogr. Sci."},{"issue":"R1","key":"10.1016\/j.jchromb.2025.124891_bb0210","volume":"Q2","year":"2005","journal-title":"Text and methodology"},{"key":"10.1016\/j.jchromb.2025.124891_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124571","article-title":"A novel quality-by-design assisted HPLC-DAD method for the simultaneous quantification of tryptophan, tryptophol, and voriconazole for early diagnosis and prognosis of fungal infections decoding quorum sensing phenomenon","volume":"1257","author":"Saleh","year":"2025","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124891_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/chir.70036","article-title":"Analytical quality by design for chiral pharmaceuticals: a robust HPLC method for upadacitinib enantiomeric quantification","volume":"37","author":"Kanaan","year":"2025","journal-title":"Chirality"},{"key":"10.1016\/j.jchromb.2025.124891_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.112220","article-title":"Development of HPLC-UV method for determination of nilotinib in spiked human plasma with greenness assessment","volume":"207","author":"Smerikarova","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2025.124891_bb0230","unstructured":"-United States Pharmacopoeial Convention; USP 41-NF 36, chapter <1225> Validation of compendial procedures; United States Pharmacopoeia: North Bethesda, 2018."},{"key":"10.1016\/j.jchromb.2025.124891_bb0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/clpt.2009.208","article-title":"Clinical pharmacokinetics of the BCR\u2013ABL tyrosine kinase inhibitor nilotinib","volume":"87","author":"Tanaka","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2025.124891_bb0240","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jcph.1414","article-title":"Characterization of the effect of hepatic impairment on upadacitinib pharmacokinetics","volume":"59","author":"Trueman","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124891_bb0245","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-14-2275","article-title":"Prognostic significance of tryptophan catabolism in adult T-cell leukemia\/lymphoma","volume":"21","author":"Masaki","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jchromb.2025.124891_bb0250","author":"International Council for Harmonisation (ICH)"},{"key":"10.1016\/j.jchromb.2025.124891_bb0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.21608\/aps.2023.166675.1100","article-title":"Spectrofluorometric determination of baricitinib in pure form and application on pharmaceutical dosage form; green profile evaluation via eco-scale and GAPI tools","volume":"6","author":"Saleh","year":"2022","journal-title":"Archives of Pharmaceutical Sciences Ain Shams University."},{"key":"10.1016\/j.jchromb.2025.124891_bb0260","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/chromsci\/bmac101","article-title":"A gadolinium-based magnetic ionic liquid for dispersive liquid\u2013liquid microextraction of ivermectin from environmental water","volume":"61","author":"Abdelaziz","year":"2023","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2025.124891_bb0265","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1039\/c1cs90064a","article-title":"Green chemistry: present and future","volume":"41","author":"Li","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jchromb.2025.124891_bb0270","article-title":"A green and versatile HPLC-DAD method for determination of silodosin and solifenacin in their newly combined formulation: evaluation of content uniformity and dissolution profiles","volume":"44","author":"Wadie","year":"2025","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2025.124891_bb0275","article-title":"Eco-friendly chromatographic platforms for simultaneous determination and impurity profiling of an antihypertensive ternary pharmaceutical mixture","volume":"32","author":"Marzouk","year":"2023","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2025.124891_bb0280","doi-asserted-by":"crossref","unstructured":"-A. Z. I. Shehata, A. A. El-Mehdawy, M. A. Mahmoud, L. A. Abou El-Khashab, A. M. Saleh, A. N. G. Abdel-Aziz, N. A. Bakr, H. F. Abd-Elkhalek, M. A. M. El-Tabakh, Greenness assessment and phototoxicity of rose bengal and methylene blue on immature aquatic stages of malaria vector Anopheles pharoensis, Sci. Rep. 15 (2025) 18324. https:\/\/www.nature.com\/articles\/s41598-025-03519-1.","DOI":"10.1038\/s41598-025-03519-1"},{"key":"10.1016\/j.jchromb.2025.124891_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.114437","article-title":"Software-assisted evaluation of sustainable chemistry innovations: a critical analytical review of viability assays incorporating diseases\u2019 biomarkers with greenness, blueness, and whiteness computational metrics","volume":"215","author":"Saleh","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2025.124891_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.109026","article-title":"A new need, quality, and sustainability (NQS) index for evaluating chemical analysis procedures using natural reagents","volume":"193","author":"Kiwfo","year":"2023","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2025.124891_bb0295","doi-asserted-by":"crossref","first-page":"38103","DOI":"10.1038\/s41598-025-22700-0","article-title":"Univariate and multivariate signal processing spectrophotometric determination of an antihypertensive combination in line with the United Nations sustainable development goals","volume":"15","author":"Kamel","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2025.124891_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.114781","article-title":"MA tool\u2014multi-color assessment platform for white analytical chemistry: unified evaluation of method greenness, practicality, performance, and innovation","volume":"216","author":"Abbas","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2025.124891_bb0305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10876-022-02224-7","article-title":"Selective viramidine-loaded aptamer-nanoparticles trigger cell cycle arrest in nucleolin-expressed hepatoma cells through modulation of CDC25A\/p53\/PI3K pathway","volume":"34","author":"Abd-Rabou","year":"2023","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.jchromb.2025.124891_bb0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-016-0430-z","article-title":"Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro","volume":"35","author":"Qu","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jchromb.2025.124891_bb0315","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.3390\/molecules16042944","article-title":"Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells","volume":"16","author":"Al-Qubaisi","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2025.124891_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109187","article-title":"Anti-cancer activity, and molecular docking of novel hybrid heterocyclic steroids revealed promising anti-hepatocellular carcinoma agent: implication of cyclin dependent kinase-2 pathway","volume":"193","author":"Tantawy","year":"2023","journal-title":"Steroids"},{"key":"10.1016\/j.jchromb.2025.124891_bb0325","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1039\/D1RA03876A","article-title":"Bioactive glass doped with noble metal nanoparticles for bone regeneration: in vitro kinetics and proliferative impact on human bone cell line","volume":"11","author":"Mostafa","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jchromb.2025.124891_bb0330","first-page":"2881","article-title":"A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry","volume":"16","author":"Qian","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jchromb.2025.124891_bb0335","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1186\/s12885-022-10201-6","article-title":"Implication of extrinsic and intrinsic apoptotic pathways in the targeted therapy of hepatocellular carcinoma using aptamer-labeled viramidine nanoparticles","volume":"22","author":"Abd-Rabou","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jchromb.2025.124891_bb0340","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.7150\/ijbs.64003","article-title":"CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2\/Bax pathway","volume":"17","author":"Zhao","year":"2021","journal-title":"Int. J. Biol. Sci."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225004453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225004453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:00:42Z","timestamp":1771520442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225004453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":68,"alternative-id":["S1570023225004453"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124891","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous chromatographic quantification of upadacitinib, nilotinib, and tryptophan decoding myeloid leukemia and liver cancer integrated with ELISA and Flow cytometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124891"}}